Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @IanSetliff
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @IanSetliff
-
Ian Setliff proslijedio/la je Tweet
#Zika virus vaccination elicits Zika and#dengue virus cross-neutralizing#antibodies in#flavivirus-exposed individuals, potentially enhancing the protective efficacy of the vaccine in flavivirus-endemic regions@wrairhttp://go.nature.com/2ueSACdHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ian Setliff proslijedio/la je Tweet
Study led by WRAIR’s Emerging Infectious Diseases Branch finds Army-developed Zika vaccine induces potent Zika and dengue cross-neutralizing antibodies. https://eurekalert.org/e/9ql1 pic.twitter.com/yeapzuIZ5m
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ian Setliff proslijedio/la je Tweet
”A large leap forward can be made if the immunotherapy target cells and pathways are characterized at high resolution before and after treatment, in clinical cohorts and model systems” Single-cell biology is about to eat drug development too!https://www.nature.com/articles/s41591-019-0736-4 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ian Setliff proslijedio/la je Tweet
Our exciting new collaboration with
@McLellan_Lab@ZABornholdt@LarryZeitlin@ChandranLab and our partners at USAMRIID. Examining the structure and role in pathogenesis of CCHFV GP38https://jvi.asm.org/content/early/2020/01/23/JVI.02005-19.abstract?papetoc …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ian Setliff proslijedio/la je Tweet
Memory B Cell Activation, Broad Anti-influenza Antibodies, and Bystander Activation Revealed by Single-Cell Transcriptomics - ScienceDirecthttps://www.sciencedirect.com/science/article/pii/S2211124719317206 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thanks for the blog post,
@OPIGlets : https://www.blopig.com/blog/2020/01/parallelising-antigen-specific-b-cell-isolation-with-libra-seq/ … . We, too, hope#libraseq will speed up mAb discovery!Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
I couldn't have had a better time during my PhD thanks to the incredible mentorship of
@ig_lab, my awesome labmates, our many great collaborators near and far, and the friends I made along the way. Thanks to all who made science so fun the last few years!https://twitter.com/LaurenW_Science/status/1216084586461126656 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ian Setliff proslijedio/la je Tweet
Happy New Year! We are excited to share two upcoming dissertation defenses from Marion Sauer, from
@MeilerLab and@croweje labs, and@IanSetliff, from@IG_lab! Make sure to check out the amazing discoveries they made.pic.twitter.com/tifgtZYP0m
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ian Setliff proslijedio/la je Tweet
An amazing story. If you take BCG, a 100 year old vaccine given intradermally with limited success, and give it intravenously, it induces robust T cell and antibody immunity that is highly protective (9/10 protected) against tuberculosis!
#GameChangerhttps://www.nature.com/articles/s41586-019-1817-8 …Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ian Setliff proslijedio/la je Tweet
The
#antibody discovery &#vaccine development research fields may be on the verge of rapidly expanding with data that previously took decades, thanks to LIBRA-seq, a new tool developed by@VanderbiltU researchers & their colleagues. Learn more: http://ow.ly/C67Y50xBw9Z pic.twitter.com/x8VfpAYnya
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ian Setliff proslijedio/la je Tweet
A new tool, LIBRA-seq, may upend
#antibody discovery and#vaccine development by simultaneously mapping antibody sequences and antigen specificities in a high throughput way.@IG_lab explains the#genomics technology in@CellCellPress. http://news.vumc.org/2019/12/12/new-tool-may-speed-antibody-vaccine-research/ …@vumcresearchHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ian Setliff proslijedio/la je Tweet
A good example of why pursuing innovative, yet high-risk,
#science should not only be encouraged and supported, but consistently prioritized, at all levels (PIs, institutions, funding agencies). Grateful for the amazing team in this study, led by@IanSetliff and@AShiakolas.https://twitter.com/VUMCResearch/status/1205523563542798336 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ian Setliff proslijedio/la je Tweet
@IG_lab has developed a new resource called LIBRA-seq, “Linking B-cell Receptor to Antigen Specificity through sequencing,” and has leveraged the technology to identify a previously unknown broadly neutralizing HIV antibody. http://news.vumc.org/2019/12/12/new-tool-may-speed-antibody-vaccine-research/ …pic.twitter.com/Z6Kt80IZwS
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ian Setliff proslijedio/la je Tweet
#ICYMI :@IG_lab#antibody paper in@CellCellPress is making a splash! "High-Throughput Mapping of B Cell Receptor Sequences to Antigen Specificity"@VUMChealth - http://bit.ly/2EgJS7M@IanSetliff@AShiakolas@VUMC_Vaccines#vaccine#computerscience#immunology#researchpic.twitter.com/NYUPBcJWy0
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ian Setliff proslijedio/la je Tweet
Researchers from
@VanderbiltU have developed LIBRA-seq, a method that leverages single cell immune sequencing to rapidly link B-cell receptors with their corresponding antigens. Hear from the lead author in a recent webinar & explore the paper on our blog. https://bit.ly/2DYrW1NHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Cool stuff by
@befcorreia and colleagues!https://twitter.com/naturemethods/status/1204149966924664833 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ian Setliff proslijedio/la je Tweet
A breakthrough in developing an effective HIV vaccine by researchers at
#DHVI &@BostonChildrens, whose study show that antibodies can be coaxed into multiplying as protective force against the virus. Congrats to all involved in this exciting discovery! https://bit.ly/2RAUWoo https://twitter.com/DukeMedSchool/status/1202958735057907713 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ian Setliff proslijedio/la je Tweet
#Engineering_B_Cell_Maturation | Targeted Selection of Improbable Mutations | to guide HIV-Specific#Antibody#AffinityMaturation | Bart Haynes@DukeMedSchool@sciencemagazine https://buff.ly/2LynxGQ pic.twitter.com/gLJKIMzPWQ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ian Setliff proslijedio/la je Tweet
Not sure what to do after that big Thanksgiving day meal? Read our fun new
#antibody paper in@CellCellPress: High-Throughput Mapping of B Cell Receptor Sequences to Antigen Specificity https://www.cell.com/cell/fulltext/S0092-8674(19)31224-3#.Xd_y6c-ZCNo.twitter …@IanSetliff@AShiakolasHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ian Setliff proslijedio/la je Tweet
A Randomized, Controlled Trial of
#Ebola Virus Disease Therapeutics | NEJMhttps://www.nejm.org/doi/full/10.1056/NEJMoa1910993 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.